These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 25740208)

  • 1. Cost-effective osteoporosis treatment thresholds in Greece.
    Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
    Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effective osteoporosis treatment thresholds for people living with HIV infection in Greece.
    Makras P; Boubouchairopoulou N; Katsarolis I; Athanasakis K
    J Musculoskelet Neuronal Interact; 2017 Dec; 17(4):292-298. PubMed ID: 29199188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX(®) in Portugal.
    Marques A; Lourenço Ó; Ortsäter G; Borgström F; Kanis JA; da Silva JA
    Calcif Tissue Int; 2016 Aug; 99(2):131-41. PubMed ID: 27016370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Su Y; Lai FTT; Yip BHK; Leung JCS; Kwok TCY
    Osteoporos Int; 2018 Aug; 29(8):1793-1805. PubMed ID: 29774400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
    Ni W; Jiang Y
    Osteoporos Int; 2017 Feb; 28(2):529-538. PubMed ID: 27581955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland.
    Lippuner K; Johansson H; Borgström F; Kanis JA; Rizzoli R
    Osteoporos Int; 2012 Nov; 23(11):2579-89. PubMed ID: 22222755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
    Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.
    Ström O; Jönsson B; Kanis JA
    Osteoporos Int; 2013 Apr; 24(4):1491-502. PubMed ID: 23224141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX.
    Borgström F; Ström O; Coelho J; Johansson H; Oden A; McCloskey EV; Kanis JA
    Osteoporos Int; 2010 Mar; 21(3):495-505. PubMed ID: 19565175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture.
    Zarca K; Durand-Zaleski I; Roux C; Souberbielle JC; Schott AM; Thomas T; Fardellone P; Benhamou CL
    Osteoporos Int; 2014 Jun; 25(6):1797-806. PubMed ID: 24691648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing and evaluating FRAX
    Chan DC; McCloskey EV; Chang CB; Lin KP; Lim LC; Tsai KS; Yang RS
    J Formos Med Assoc; 2017 Mar; 116(3):161-168. PubMed ID: 27117886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.
    Hiligsmann M; Ben Sedrine W; Bruyère O; Reginster JY
    Osteoporos Int; 2013 Aug; 24(8):2291-300. PubMed ID: 23371359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Moriwaki K; Noto S
    Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Mori T; Crandall CJ; Ganz DA
    Osteoporos Int; 2017 May; 28(5):1733-1744. PubMed ID: 28210776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women.
    Chandran M; Ganesan G; Tan KB; Reginster JY; Hiligsmann M
    Osteoporos Int; 2021 Jan; 32(1):133-144. PubMed ID: 32797250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.
    Cui L; He T; Jiang Y; Li M; Wang O; Jiajue R; Chi Y; Xu Q; Xing X; Xia W
    Osteoporos Int; 2020 Feb; 31(2):307-316. PubMed ID: 31754756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
    Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A health economic simulation model for the clinical management of osteoporosis.
    Jonsson E; Hansson-Hedblom A; Ljunggren Ö; Åkesson K; Spångeus A; Kanis JA; Borgström F
    Osteoporos Int; 2018 Mar; 29(3):545-555. PubMed ID: 29196775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
    Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis.
    Borgström F; Johnell O; Kanis JA; Jönsson B; Rehnberg C
    Osteoporos Int; 2006 Oct; 17(10):1459-71. PubMed ID: 16847588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.